"... There were five sudden deaths reported in patients receiving nilotinib in an on-going study (n=867; 0.6%). A similar incidence was also reported in the expanded access program. The relative early occurrence of some of these deaths relative to the initiation of nilotinib suggests the possibility that ventricular repolarization abnormalities may have contributed to their occurrence... "
- Tasigna Information for Consumers
- Tasigna Information for Healthcare Professionals (includes dosage details)
- Side Effects of Tasigna (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 7 Jun 2010 • 4 answers
Posted 18 Apr 2014 • 1 answer
Posted 7 Aug 2014 • 1 answer
Posted 18 Aug 2014 • 1 answer
Posted 7 May 2016 • 0 answers